Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
Issued Date
2024-01-01
Resource Type
eISSN
20597029
Scopus ID
2-s2.0-85190264567
Journal Title
ESMO Open
Rights Holder(s)
SCOPUS
Bibliographic Citation
ESMO Open (2024)
Suggested Citation
Park K.H., Loibl S., Sohn J., Park Y.H., Jiang Z., Tadjoedin H., Nag S., Saji S., Md. Yusof M., Villegas E.M.B., Lim E.H., Lu Y.S., Ithimakin S., Tseng L.M., Dejthevaporn T., Chen T.W.W., Lee S.C., Galvez C., Malwinder S., Kogawa T., Bajpai J., Brahma B., Wang S., Curigliano G., Yoshino T., Kim S.B., Pentheroudakis G., Im S.A., Andre F., Ahn J.B., Harbeck N. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer. ESMO Open (2024). doi:10.1016/j.esmoop.2024.102974 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/98045
Title
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
Author(s)
Park K.H.
Loibl S.
Sohn J.
Park Y.H.
Jiang Z.
Tadjoedin H.
Nag S.
Saji S.
Md. Yusof M.
Villegas E.M.B.
Lim E.H.
Lu Y.S.
Ithimakin S.
Tseng L.M.
Dejthevaporn T.
Chen T.W.W.
Lee S.C.
Galvez C.
Malwinder S.
Kogawa T.
Bajpai J.
Brahma B.
Wang S.
Curigliano G.
Yoshino T.
Kim S.B.
Pentheroudakis G.
Im S.A.
Andre F.
Ahn J.B.
Harbeck N.
Loibl S.
Sohn J.
Park Y.H.
Jiang Z.
Tadjoedin H.
Nag S.
Saji S.
Md. Yusof M.
Villegas E.M.B.
Lim E.H.
Lu Y.S.
Ithimakin S.
Tseng L.M.
Dejthevaporn T.
Chen T.W.W.
Lee S.C.
Galvez C.
Malwinder S.
Kogawa T.
Bajpai J.
Brahma B.
Wang S.
Curigliano G.
Yoshino T.
Kim S.B.
Pentheroudakis G.
Im S.A.
Andre F.
Ahn J.B.
Harbeck N.
Author's Affiliation
Korea University Anam Hospital
Siriraj Hospital
Rumah Sakit Kanker Dharmais
Yonsei Cancer Hospital
Sun Yat-Sen University Cancer Center
Homi Bhabha National Institute
National Taiwan University Hospital
General Hospital of People's Liberation Army
National Yang-Ming University Taiwan
Asan Medical Center
Cancer Institute Hospital of Japan Foundation for Cancer Research
National Cancer Centre, Singapore
Istituto Europeo di Oncologia
Università degli Studi di Milano
Institut de Cancerologie Gustave Roussy
Seoul National University Hospital
Samsung Medical Center, Sungkyunkwan university
Faculty of Medicine Ramathibodi Hospital, Mahidol University
National Cancer Center Hospital East
Pantai Holdings Sdn Bhd
Goethe-Universität Frankfurt am Main
Fukushima Medical University
Klinikum der Universität München
St. Luke's Medical Center Global City
Sahyadri Super Speciality Hospital
ESMO
National University Cancer Institute
Cebu Doctors University Hospital
Siriraj Hospital
Rumah Sakit Kanker Dharmais
Yonsei Cancer Hospital
Sun Yat-Sen University Cancer Center
Homi Bhabha National Institute
National Taiwan University Hospital
General Hospital of People's Liberation Army
National Yang-Ming University Taiwan
Asan Medical Center
Cancer Institute Hospital of Japan Foundation for Cancer Research
National Cancer Centre, Singapore
Istituto Europeo di Oncologia
Università degli Studi di Milano
Institut de Cancerologie Gustave Roussy
Seoul National University Hospital
Samsung Medical Center, Sungkyunkwan university
Faculty of Medicine Ramathibodi Hospital, Mahidol University
National Cancer Center Hospital East
Pantai Holdings Sdn Bhd
Goethe-Universität Frankfurt am Main
Fukushima Medical University
Klinikum der Universität München
St. Luke's Medical Center Global City
Sahyadri Super Speciality Hospital
ESMO
National University Cancer Institute
Cebu Doctors University Hospital
Corresponding Author(s)
Other Contributor(s)
Abstract
The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer were updated and published online in 2023, and adapted, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with early breast cancer. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with breast cancer representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), co-ordinated by ESMO and KSMO. The voting was based on scientific evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different Asian regions represented by the 10 oncological societies. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with early breast cancer across the different regions of Asia, drawing on the evidence provided by both Western and Asian trials, whilst respecting the differences in screening practices, molecular profiling, as well as the age and stage at presentation. Attention is drawn to the disparity in the drug approvals and reimbursement strategies, between the different regions of Asia.